Discover your next big idea at PACK EXPO Las Vegas this September
Experience a breakthrough in packaging & processing and transform your business with solutions from 2,300 suppliers spanning all industries.

FDA analyst delivers medical device labeling details

EASTPACK : At a June 6 Medical Design & Manufacturing East conference session, Food and Drug Administration regulatory policy analyst Arthur Yellin offered the following advice on medical device labeling:

• The Food, Drug and Cosmetic Act defines a label as information on the immediate container and does not include package liners. Labeling refers to all labels and “other written, printed, or graphic matter” on or “accompanying” a regulated product.

• Labeling must be truthful and complete. It may not be misleading in any respect. All required information must be clearly readable and understandable.

• Although the FDA does not define a minimum type size, generally 6-pt-type is the smallest acceptable for required information.

• Prohibited from use on medical device labeling are references to 510(k) clearance, false or misleading statements, undefinable superlatives such as superior, best, or strongest, and the term “hypoallergenic” for latex-containing devices.

• If only a distributor is named, it must be identified as “manufactured for…” or “distributed by…” or similar wording.

• Devices manufactured with components from multiple countries need to be labeled with the predominant source country. Yellin noted this is required by the U.S. Customs Service, not the FDA.

• At least one intended use of the device must be specified.

• Directions for use of over-the-counter devices should be such that a lay person could use the device safely for its intended purpose. Prescription devices, for which directions for lay persons cannot be written, must be labeled with indications for use, effects, routes, methods, frequency and duration of use, hazards, contraindications and precautions, as well as known side effects.

• A tricky one: If the labeling contains any representation in a foreign language, then all required words, statements, and other information must also appear on the labeling in that foreign language.

• Condoms, medical gloves, and latex-containing medical devices, Yellin said, represent products require special labeling.

• In-vitro diagnostic devices must be labeled as required by 21 CFR 809.10, and include proprietary and established names, intended use, the established name and quantity if it’s a reagent, and storage instructions for the reagent, the expiration date, information about deterioration, the name and address of the manufacturer, packer, or distributor, and the lot or control number.

For additional information and guidance, Yellin offered three Web sites:

For device advice, visit www.fda.gov/dcrh/devadvice/33.html.

For Write it right, visit www.fda.gov/cdrh/dsma/897.pdf.

For the Division of Small Manufacturers, International and Consumer Assistance, send an e-mail to [email protected].

Annual Outlook Report: Automation & Robotics
What's in store for CPGs in 2025 and beyond? <i>Packaging World</i> editors explore the survey responses from 118 brand owners, CPG, and FMCG <i>Packaging World</i> readers for its new Annual Outlook Report.
Download
Annual Outlook Report: Automation & Robotics
Conveying Innovations Report
Editors report on distinguishing characteristics that define each new product and collected video demonstrating the equipment or materials as displayed at the show. This topical report, winnowed from nearly 300 PACK EXPO collective booth visits, represents a categorized, organized account of individual items that were selected based on whether they were deemed to be both new, and truly innovative, based on decades of combined editorial experience in experiencing and evaluating PACK EXPO products.
Take me there
Conveying Innovations Report